Most patients experience rapid progress during the first one to two years as the stomach volume decreases, appetite hormones shift, and caloric intake naturally falls
Yet, their potential can only be fully realized with delivery devices that are equally innovative, reliable, and patient-friendly
Semaglutide is a GLP-1 receptor agonist thats similar to in cretin, a naturally-occurring hormone that controls your appetite
When injection is completed, the ameroid constrictor device (Research Instruments SW, Lebanon, OR) is placed around the vessel at the location of vessel loop occlusion
If you're considering a GLP-1 medication and would like support building a plan that works alongside your treatment, our Medical Weight Loss Program may be able to help
This is the part to plan around